These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 38196188)
1. The pathogenic role of the immune system in erectile dysfunction and Peyronie's disease: focusing on immunopathophysiology and potential therapeutic strategies. Giagulli VA; Lisco G; De Tullio A; Guastamacchia E; Triggiani V; Jirillo E Sex Med Rev; 2024 Mar; 12(2):210-220. PubMed ID: 38196188 [TBL] [Abstract][Full Text] [Related]
2. [Biotherapies for erectile dysfunction and Peyronie's disease: Where are we now?]. Akakpo W; Schirmann A; Ferretti L; Ben-Naoum K; Carnicelli D; Graziana JP; Hupertan V; Madec FX; Marcelli F; Methorst C; Morel-Journel N; Savareux L; Terrier JE; Faix A; Huyghe E; Yiou R Prog Urol; 2020 Dec; 30(16):1000-1013. PubMed ID: 32826194 [TBL] [Abstract][Full Text] [Related]
3. Platelet-Rich Plasma Therapy for Male Sexual Dysfunction: Myth or Reality? Epifanova MV; Gvasalia BR; Durashov MA; Artemenko SA Sex Med Rev; 2020 Jan; 8(1):106-113. PubMed ID: 30898594 [TBL] [Abstract][Full Text] [Related]
4. Peyronie's disease: new paradigm for the treatment of a unique cause of erectile dysfunction. Carson C Postgrad Med; 2020 Dec; 132(sup4):4-8. PubMed ID: 33156731 [TBL] [Abstract][Full Text] [Related]
5. Erectile dysfunction and Peyronie's disease diagnosis rates after penile fracture-a retrospective claims database cohort analysis. Maremanda AP; Du Comb W; Able C; Kohn TP; Unal S; Burnett AL Int J Impot Res; 2024 Apr; 36(2):125-128. PubMed ID: 37542153 [TBL] [Abstract][Full Text] [Related]
6. Platelet-Rich Plasma Injections for Erectile Dysfunction and Peyronie's Disease: A Systematic Review of Evidence. Alkandari MH; Touma N; Carrier S Sex Med Rev; 2022 Apr; 10(2):341-352. PubMed ID: 34219010 [TBL] [Abstract][Full Text] [Related]
7. Low testosterone has a similar prevalence among men with sexual dysfunction due to either Peyronie's disease or erectile dysfunction and does not correlate with Peyronie's disease severity. Kirby EW; Verges D; Matthews J; Carson CC; Coward RM J Sex Med; 2015 Mar; 12(3):690-6. PubMed ID: 25580982 [TBL] [Abstract][Full Text] [Related]
8. Peyronie's disease. Pryor J; Akkus E; Alter G; Jordan G; Lebret T; Levine L; Mulhall J; Perovic S; Ralph D; Stackl W J Sex Med; 2004 Jul; 1(1):110-5. PubMed ID: 16422991 [TBL] [Abstract][Full Text] [Related]
9. Adipose tissue-derived stem cell therapy for prevention and treatment of erectile dysfunction in a rat model of Peyronie's disease. Gokce A; Abd Elmageed ZY; Lasker GF; Bouljihad M; Kim H; Trost LW; Kadowitz PJ; Abdel-Mageed AB; Sikka SC; Hellstrom WJ Andrology; 2014 Mar; 2(2):244-51. PubMed ID: 24574095 [TBL] [Abstract][Full Text] [Related]
10. Stem-cell therapy for erectile dysfunction. Albersen M; Lin CS; Lue T Arab J Urol; 2013 Sep; 11(3):237-44. PubMed ID: 26558088 [TBL] [Abstract][Full Text] [Related]
11. Erectile dysfunction following surgical correction of Peyronie's disease and a pilot study of the use of sildenafil citrate rehabilitation for postoperative erectile dysfunction. Levine LA; Greenfield JM; Estrada CR J Sex Med; 2005 Mar; 2(2):241-7. PubMed ID: 16422892 [TBL] [Abstract][Full Text] [Related]
12. The treatment of loss of penile rigidity associated with Peyronie's disease. Krane RJ Scand J Urol Nephrol Suppl; 1996; 179():147-50. PubMed ID: 8908682 [TBL] [Abstract][Full Text] [Related]
14. Extracorporeal shock wave therapy (ESWT) in urology: a systematic review of outcome in Peyronie's disease, erectile dysfunction and chronic pelvic pain. Fojecki GL; Tiessen S; Osther PJ World J Urol; 2017 Jan; 35(1):1-9. PubMed ID: 27108421 [TBL] [Abstract][Full Text] [Related]
15. Treatment of erectile dysfunction in patients with Peyronie's disease using sildenafil citrate. Levine LA; Latchamsetty KC Int J Impot Res; 2002 Dec; 14(6):478-82. PubMed ID: 12494281 [TBL] [Abstract][Full Text] [Related]
16. Phosphodiesterase type 5 in men with vasculogenic and post-radical prostatectomy erectile dysfunction: is there a molecular difference? Karakus S; Musicki B; Burnett AL BJU Int; 2018 Dec; 122(6):1066-1074. PubMed ID: 29888556 [TBL] [Abstract][Full Text] [Related]
17. Penile Doppler sonographic and clinical characteristics in Peyronie's disease and/or erectile dysfunction: an analysis of 1500 men with male sexual dysfunction. Chung E; Yan H; De Young L; Brock GB BJU Int; 2012 Oct; 110(8):1201-5. PubMed ID: 22313546 [TBL] [Abstract][Full Text] [Related]
18. Microstructural disorders of tunica albuginea in patients affected by Peyronie's disease with or without erection dysfunction. Iacono F; Barra S; De Rosa G; Boscaino A; Lotti T J Urol; 1993 Dec; 150(6):1806-9. PubMed ID: 8230510 [TBL] [Abstract][Full Text] [Related]
19. Intratunical Injection of Genetically Modified Adipose Tissue-Derived Stem Cells with Human Interferon α-2b for Treatment of Erectile Dysfunction in a Rat Model of Tunica Albugineal Fibrosis. Gokce A; Abd Elmageed ZY; Lasker GF; Bouljihad M; Braun SE; Kim H; Kadowitz PJ; Abdel-Mageed AB; Sikka SC; Hellstrom WJ J Sex Med; 2015 Jul; 12(7):1533-44. PubMed ID: 26062100 [TBL] [Abstract][Full Text] [Related]
20. Shockwave Therapy in the Treatment of Peyronie's Disease. Krieger JR; Rizk PJ; Kohn TP; Pastuszak A Sex Med Rev; 2019 Jul; 7(3):499-507. PubMed ID: 30926460 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]